TriSalus Life Sciences, Inc. TLSI Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s total liabilities & equity?
- TriSalus Life Sciences, Inc. (TLSI) reported total liabilities & equity of $70.98M in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s total liabilities & equity changed year-over-year?
- TriSalus Life Sciences, Inc.'s total liabilities & equity increased by 148.0% year-over-year, from $28.63M to $70.98M.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), TriSalus Life Sciences, Inc.'s total liabilities & equity has grown at a -32.5% compound annual growth rate (CAGR), from $252.01M to $35.33M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.